In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

The National Comprehensive Cancer Network’s newly updated non-small cell lung cancer guideline adds sevabertinib as a treatment option for some patients with advanced disease, makes datopotamab ...

By: Dr. Amrit Kaur Kaler For patients diagnosed with blood cancers such as leukemia, lymphoma, and multiple myeloma, the ...

Author Capital Partners ("Author Capital" or "AuthorCap"), a Chicago-based principal investment firm, in partnership with ...

The molecular HPV test, replacing the Pap test, allows early detection of high-risk HPV strains. LEM Lab expands testing, including self-tests, to fight cervical cancer.

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

Unlike common enzyme immunoassay methods (ELISA), mass spectrometry accurately determines the mass of molecules, ensures high ...

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix), a life sciences ...

MUSCAT: The Royal Hospital succeeded in localising molecular tests for colorectal cancer (KRAS, NRAS, BRAF) as part of ...

Key opportunities in the Global Esoteric Testing Market include addressing rising chronic disease rates, demand for molecular diagnostics in personalized medicine, and expanding use of liquid biopsy ...